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Laminin 332, composed of the a3, b3 and c2 chains, is an
epithelial-basement membrane specific laminin variant. Its
main role in normal tissues is the maintenance of epithelial-
mesenchymal cohesion in tissues exposed to external forces,
including skin and stratified squamous mucosa. After being
secreted and deposited in the extracellular matrix, laminin 332
undergoes physiological maturation processes consisting in
the proteolytic processing of domains located within the a3
and the c2 chains. These maturation events are essential for
laminin 332 integration into the basement membrane where it
plays an important function in the nucleation and mainten-
ance of anchoring structures. Studies in normal and patho-
logical situations have revealed that laminin 332 can trigger
distinct cellular events depending on the level of its
proteolytic cleavages. In this review, the biological and
structural characteristics of laminin 332 domains are presented
and we discuss whether they trigger specific functions.
Laminins are large extracellular glycoproteins that are important
components of all basement membranes. They are involved in
several biological processes, including self polymerization, binding
to the extracellular matrix (ECM) and cellular interactions.1,2 All
laminins are composed of three different gene products, termed a,
β and c chains assembled into a cross-shaped heterotrimer aβc.
The three chains assemble within the endoplasmic reticulum
through their C-terminal domains to form a triple stranded
a-helical coiled coil rod.3,4 Sixteen laminin isoforms of different
subunit composition selected from five individual a chains (a1 to
a5), three β chains (β1 to β3) and three c chains (c1 to c3), are
known with variable cell and tissue specific expression, and they
are differentially recognized by cellular receptors.5 All laminin a
chains possess a large globule at the carboxyl-terminal end that
consists of five similar domains LG1 to LG5 each containing
about 200 residues.6,7
Laminin 332 and Its Maturation Events
Laminin 332, composed of the a3, β3 and c2 chains, is an
epithelial-basement membrane specific variant. The a3 chain is
encoded by the LAMA3 gene, which has two transcript variants
a3A and a3B. As the truncated LAMA3A variant is expressed and
incorporated into laminin 332 heterotrimers,8 we will refer to the
a3Aβ3c2 trimer as representing laminin 332 in this review. Its
main role in normal tissues is the maintenance of epithelial-
mesenchymal cohesion in tissues exposed to external forces
including skin and stratified squamous mucosa.9,10 To fulfill this
function, laminin 332 undergoes several physiological post-
translational processing events allowing its supramolecular
integration into the basement membrane. In other situations
such as wound healing or carcinoma, additional cleavages may
take place delivering pro-migratory signals to cells therefore
compromising the adhesive function of the protein.
Laminin 332 processing and integration into the skin
basement membrane. In skin, laminin 332 is synthesized by
keratinocytes as a high molecular weight precursor protein of 460
kDa. After secretion and deposition into the ECM, the a3 and c2
chains undergo maturation events consisting in specific processing
to smaller forms.4,11 The 190–200 kDa a3 chain (a3200) can be
successively processed at both C- and N-terminal extremities
producing 165 (a3165) and 145 kDa (a3145) maturation
products. The 155 kDa c2 chain (c2155) is processed in the N-
terminal region leading to a 105 kDa product (c2105).
Processing of the a3 chain consists of cleavage of the C-
terminal globular domains 4 and 5 (LG45) within the spacer
between LG3 and LG4 (Fig. 1A and B).12,13 In vitro studies using
human laminin 332 have revealed that enzymes involved in the
processing include plasmin,12 MMP-2, MT1-MMP and the C-
proteinase family of enzymes, especially mammalian tolloid
(mTLD) and the bone morphogenic protein 1 (BMP-1).14,15 In
addition, thrombin was shown to have the potency to cleave
LG45 specifically.16 Alternatively, there may be other mechanisms
that control the rate of laminin a3 LG45 processing, such as the
tissue plasminogen proteolytic cascade.12 N-terminal amino acid
sequencing of human LG45 purified from the conditioned
medium of either primary or immortalized human keratinocytes
and of the human gastric adenocarcinoma cells STKM-1 revealed
that the a3 chain is cleaved between Q1337 and D1338 within the
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hinge region between LG3 and LG4 suggesting that a proteolytic
cleavage site of the LG45 domain matches the minimal consensus
sequence LLQD (Fig. 1B).17,18 It is not known what endopepti-
dase catalyzes the hydrolysis of this cleavage sequence, and the
existence of additional proteolytic cleavage sites has been
suspected both in the hinge and the adjacent regions of the
LG3 and LG4 domains.7,13,14,19 This hypothesis is compatible
with the spacer length of the laminin a3 chain, which is longer
than those of the a1, a2 and a5 chains.7 Punctual mutations
within the spacer region and/or deletion of the sequence LLQD
did not protect the a3 LG3-LG4 linker from cleavage.14,19 As
proteolytic processing of LG domains occurs in all a chains except
a1, the substitution of the a3 LG3-LG4 hinge with that of the a1
chain was an elegant way to render the laminin a3 chain
uncleavable.19 This was also the case when a 46 amino-acid
portion within the a3 LG3-LG4 hinge was deleted.16 These
LG45-uncleavable a3 chain constructs were expressed in human19
or mouse16 skin keratinocytes deficient for expression of the a3
chain, and in both cases the resulting LG45-uncleavable
heterotrimeric laminin 332 was deposited in the ECM.
Information gained from the structure of the mouse a2 chain
LG45 domain pair revealed an unusual path of the LG3-LG4
linker as it forms an inter-domain disulfide bridge to LG5.20
Being integrated into the LG45 tandem the linker is therefore an
integral part of the structure, a feature that is conserved in all
laminin a chains. It is tempting to speculate that proteinases may
have easy access to the LG3-LG4 cleavage sites located within a
well-exposed linker.7
Further cleavage occurs in the N-terminal LE region of the a3
chain releasing the full short arm which might be important for
laminin 332 function (Fig. 1A).14,21 A mutation causing an N-
terminal deletion of 226 amino acids in the human a3A isoform
was identified in the laryngo-oncho-cutaneous syndrome, a rare
autosomal recessive disorder characterized by chronic production
of vascularized granulation tissue.22 Cultured keratinocytes
obtained from patients revealed that heterotrimeric laminin 332
carrying the mutant a3 chain is assembled and secreted. The
mutated laminin was regularly expressed in the skin basement
membrane and only very subtle ultrastructural changes were seen
such as focal widening of the lamina lucida in places where
hemidesmosome plaques were smaller. These studies suggest that
the laminin a3 N-terminal domain may be a key regulator of the
granulation tissue response during wound healing.
In human skin laminin 332, the processing of the c2155 chain
leads to the c2105 subunit and was shown to be achieved by BMP-
1 and mTLD metalloproteinases.11,14,15,23,24 The N-terminal
processing is complex as it occurs within a disulfide-linked loop
of the L4 domain followed by reshuffling of disulfide bonds for
release of the cleaved fragments.24 The immunohistochemical
analysis of laminin 332 in mTLD/BMP-1-deficient mouse skin
revealed a strong expression of the precursor c2 chain confirming
that these enzymes are involved in the c2 chain maturation in
vivo.25 In contrast, the processing of the LG45 domain in the a3
chain seemed, at least partially, unaffected reinforcing the
hypothesis that several enzymes are involved in this maturation
process.
Laminin 332 was shown to be the major component of
anchoring filaments in skin9 where it mediates cell adhesion via
interaction of the a3 carboxyl-terminal LG1–3 triplet domain
with both a3β1 and a6β4 integrins,26-29 while the N-terminal
short arms connect to basement membrane components. Laminin
332 can be incorporated into the basement membrane through at
least two mechanisms. The first involves cross-linking of laminin
332 with laminin 311 (a3β1c1) in the skin basement
membrane.21 The complex of laminin 311 with laminin 332 is
most likely to derive from an interaction of domain LN in the β3
chain of laminin 332 with domain LE of the a3 chain short arm
in laminin 311 (see below). As seen on rotary shadowing electron
micrographs of the complex, the LN domain of the short arm
interacts with a laminin 311 domain near the intersection of the
laminin 311 short arms.21 These complexes are most likely
stabilized by a disulfide bridge between an unpaired cysteine in
domain LN of the β3-chain and domain LE of processed a3 in
laminin 311. A similar complex between laminin 332 and laminin
321 (a3β2c1) is found in the basement membrane of the
amnions. According to the 3-arm interaction hypothesis of
laminin polymerization,30 the dimers could self-associate. The
second mechanism reports a direct interaction between anchoring
filaments and anchoring fibrils. Anchoring fibrils are disulfide
bond stabilized dimers of type VII collagen.31 Monomeric laminin
332 as well as the laminin 332/311 dimer directly bind the
N-terminal globular domain NC1 of type VII collagen.10,32 The
interaction is likely to occur within the short arm of the β3 and/or
c2 subunit.32
Other processing events in laminin 332. In addition to the
laminin 332 maturation aimed at regulating the skin basement
membrane structural integrity, other studies have reported two
specific migration-inducing MMP-2 cleavages of the laminin c2
N-termini producing c2 chain fragments of 100 and 80 kDa.33
These c2 processing could also be carried by MT1-MMP in colon
and breast carcinoma cells.34 Both enzymes, that were first shown
to cleave rat laminin 332, were proposed to also cut down human
laminin 332 in both physiological and pathological situations
such as tumorigenesis.35,36 MMP-3, -12, -13, -19 and -20 were
also shown to process the c2 chain inducing epithelial cell
migration.37,38 Migration events might therefore result from the
interaction of newly exposed laminin domains with cell surface
signaling receptors. Rat recombinant c2LEb1-LEb4’ was shown
to bind and activate the EGF receptor to stimulate cell
migration.39 Studies with cancer cells have reported that MMP-
7, MT1-MMP and hepsin cleave laminin β3 leading to increased
migration.40-42 The molecular mechanisms of laminin 332 in
squamous carcinoma have been reviewed in detail by
Marinkovich.43
Laminin 332 Sequence-Structure Relationship
The structure of the heterotrimeric laminin 332 molecule
consisting of disulfide-linked a3, β3 and c2 chains was first
revealed by rotary shadowing electron microscopy, which showed
a rod 107 nm in length terminated by one large and two small
globules at opposite ends9 which correspond to the C-terminal
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Figure 1. Structure of human laminin 332 and its physiological maturation process. (A) Laminin 332 is composed of three subunits a3A, b3 and c2. Each
chain is composed of different domains that are indicated. Domain L4 in the c2 chain corresponds to an LE domain with a ~180 residues insert between
the third and fourth cysteine of the canonical 8-Cys pattern. LE4’ and LEb4’ of the a3A and c2 chain are truncated LE repeats containing only the first four
and six cysteines, respectively, of the pattern. Based on the odd number of cysteines, b3LN, a3ALE4’, b3LE6 and c2LEb1 (after maturation), and the coiled
coil of a3 have free SH groups as indicated. The coiled coil is stabilized by disulfide bonds at the N-terminus (dotted lines) though the connectivity is yet
unknown. The large LG structure located at the C-terminal end of the a3 chain contains five repeating LG domains. The first three repeats (LG1–3)
interact with a3b1, a6b1 and a6b4 integrins while the last two (LG45) contain binding sites for syndecan-1 and -4. Laminin 332 is synthesized as a
precursor molecule that undergoes maturation by proteolytic processings at the a3A chain N- and C-terminus as well as at the c2 chain N-terminal
extremity. The cleavage sites are indicated by arrows as well as enzymes involved identified so far. (B) Schematic structures of LG. The five LG domains
contain numerous cysteines that are numbered. Disulfide bridged and free cysteines (SH) within the human sequence are indicated. At the bottom, an
alignment of the human and mouse LG3-LG4 linker is shown. Each sequence displays the same cleavage site (underlined) and a cysteine (printed in
inverse font) that forms an inter-domain disulfide bond to LG5.20 The sequence P1312PFLMLLKGSTR supposed to be crucial for integrin a3b1 binding58 is
double underlined.
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LG and N-terminal LN and LE/L4 domains, respectively
(Fig. 1A). This length is consistent with the later determined
sequences which indicate that ca. 570 residues per chain
contribute to the three stranded a-helical coiled coil structure
giving a length of ~80 nm, and ~7 tandem LE domains
accounting for a further 20 nm. Circular dichroism spectroscopy
revealed an a-helical content of ~30%44 similar to that
determined for laminin 11145 suggesting that most of this
secondary structure contribution relates to the coiled coil.
Assembly of the laminin 332 trimer occurs in the endoplasmic
reticulum where first a disulfide linked β3-c2 dimer is formed to
which the a3 chain aligns via the coiled coil. Trimer formation is
a prerequisite for transport to the Golgi complex and secretion but
does not require N-linked glycosylation.4
Laminin β3 LN domain. So far no high resolution structures of
laminin 332 domains have been solved. However, based on
sequence similarity, some insight into the molecular organization
of various domains can be anticipated from homology modeling.
Recently, the crystal structure of the N-terminal LN domain
together with four adjacent LE modules of the mouse laminin β1
chain has been solved (pdb code: 4aqs).46 The corresponding
regions of human laminin β3 can be fitted to this structure
(Fig. 2) suggesting that LN (residues 18–248; accession number
NP_000219) forms a β-sandwich consisting of eight β-strands
folded into a jelly roll motif. The first LE domain (res. 249–314)
is tightly integrated into LN, which starts with a disulfide-bonded
reverse turn connected by C21–C26, and the N-terminal region
(res. 18–28) associates to LE1. Pro28, which is conserved in all
laminin LN sequences, fits into a pocket of LE1. Further disulfide
bonds can be expected between C47-C69, C56-C66 and C153-C173
(Fig. 2A). This leaves C67, which is unique for β3 LN domains
and surface accessible (Fig. 2B), in a reduced state making it
available for covalently binding to other proteins like laminin 331.
The N-linked glycosylation sites found within β1 LN at N120 and
in c1 LN at N58/N132 are absent in the β3 chain. The critical
residues D106 and T114 of c1 LN involved in calcium binding,46
which might be important for laminin polymerization, are
replaced by S70 and R76 in the β3 chain indicating that this site
will not be functional.
Laminin 332 LE and L4 domains. A common feature of LE
modules is their connectivity of the eight cysteine residues as C1-
C3, C2-C4, C5-C6 and C7-C8. The loop formed between C5-
C6 usually consists of eight residues with a glycine in position six.
In human laminin 332, the following LE domains deviate from
the 8-Cys pattern (Fig. 1A): β3-LE6 preceding the coiled coil
contains one extra cysteine (C572) between C7 and C8 whereas
the corresponding region within a3A-LE4’ is truncated after the
fourth cysteine (C185; accession number AAA59483) followed by
an irregular cysteine (C199) just before C202/C205, which are
presumably forming intrachain disulfides at the N-terminus of the
coiled coil. The a3A chain is processed just after LE4’ between
K191 and D192.14 LEb1 following domain L4 of the human c2
chain is missing the fifth cysteine of the 8-Cys pattern and does
not contain the glycine residue N-terminal to the sixth cysteine
(C442; accession number NP_005553). This probably results in
an increased mobility of the loop between C431 and C442 allowing
for protease susceptibility. Indeed, major processing occurs by
cleavage of the G434-D435 site (Fig. 1A).23
The L4 domain separating LEa3 and LEb1 can be regarded as a
specialized LE domain with a large, ~180 residues long insert
between the third (C196) and fourth (C382) cysteine of the regular
pattern. In case of the c2 chains, the L4 insert is highly conserved
from human down to Xenopus and zebrafish, and contains one
unique cysteine absent in all other L4 domains. For L4-LEb1 it
was shown that this C309 is covalently linked with the last cysteine
C459 of LEb1, which contains an unusual S-S bridge between
C442-C445 corresponding to C6-C7. After cleavage by BMP-1
between G434 and D435, protein disulfide isomerase was required
to release the fragments.24 It remains unclear whether after
processing C459 stays in a reduced state, or whether disulfide
reshuffling might form the usual C7-C8 connectivity and leaves
C6, i.e., C442, with a free SH group.24 The mouse L4-LEb1
domain pair was modified probably via one or both of the two
putative NxT acceptor sites for N-linked glycosylation, which are
also found in the human sequence (N342 and N362). The N342xT
site is conserved down to zebrafish. Mouse L4-LEb1 binds
heparin, nidogen-1 (but not -2), and fibulin-1 and -2; it remains
unclear whether these interactions occur between L4 or LEb1, or
whether epitopes from both are required.24
In conclusion, besides the β3 LN domain, each of the three
irregular LE modules, a3A-LE4’, β3-LE6 and c2-LEb1 after
processing, have one free cysteine which could participate either in
interchain disulfide bonding or covalent binding to other proteins
like laminins 311 and/or 321. Based on the canonical cysteine
pattern, the most likely residues are a3A-C199, β3-C572 and
c2-C442 or c2-C459.
Laminin 332 coiled coil and Lβ domain. Carboxyl terminal to
the LE modules, the three laminin chains have a C-x-x-C motif
(a3A: C202- C205; β3: C581-C582; c2: C609-C612) which cysteines
are conserved in all laminins and most likely serve for interchain
covalent linkage of the heterotrimer.The actual disulfide pattern
has not yet been established. The following ~570 residues
associate via formation of an a-helical coiled coil represented on
the sequence level by a 3–4 heptad pattern of hydrophobic
residues.3 As it is the case for all β chains, the β3 coiled coil is
interrupted by domain Lβ ~200 residues away from the C-x-x-C
motif containing six cysteines (human β3: C788-C818) probably
forming intrachain disulfide bonds. The a3 chain coiled coil
contains one cysteine (human a3: C551) about 50 nm from the
C-x-x-C motif, which has no adjacent counterpart in the other
two chains. The coiled coil region is terminated by cysteines close
to the C-terminus (human β3: C1171; c2: C1184), which based on
similarity to the β1 and c1 chains most probably form an
interchain disulfide bond.48
Besides its structural importance for assembly, it has recently
been found that in the absence of the LG domains the laminin
111 coiled coil has anti-adhesive properties. When cultured on
such truncated laminin 111, cell adhesion and spreading were
inhibited; genes compatible with a pro-migratory and pro-invasive
function like MMPs and various matricellular proteins were
upregulated.47 No comparable studies have yet been performed
for laminin 332, but an antagonistic interplay between coiled-coil
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and LG domains (see below) could be of importance in cancer
metastasis.
Laminin a3 LG domains. The large globule seen in electron
micrographs at the tip of the long arm consists of five LG domains
formed by the a chains. Domains LG4-LG5 are separated from
LG1 to LG3 by a flexible linker (Fig. 1B). As these domains are
involved in many interactions (see below), particular interest has
been focused on their structural characterization (for a review, see
ref. 7). X-ray structures have been solved for the mouse a5 LG1-
LG3 triplet (pdb code: 2wjs),49 mouse a1 and a2 LG45 pair
(2jd4,50 1dyk,20 1okq51), and mouse a2 LG5 (1qu052) which can
be used to model the corresponding a3 LG1-LG5 domains
(Fig. 3). LG domains fold to a β-sandwich consisting of 14
strands, where the two sheets form a concave and convex
interface. Close to the C-terminus, each LG sequence contains
two cysteines ~30 residues apart, which form intradomain
disulfide bonds (Fig. 3A and C). In contrast to electron
micrographs suggesting close proximity of LG1 to LG3,53,54 the
a2 LG1–3 structure shows LG1 dissociated from the LG2-LG3
pair.49 Previous work suggested that trimerization of the a with β
and c chains is required for the LG domain to exert its integrin
binding activity, and that specifically a glutamic acid two residues
Figure 2. Structural model of the human laminin b3 LN-LE1–4 domains. (A) The structure shows residues Q18 to Q464 as a cartoon with red cylinders and
blue arrows indicating a-helices and b-strands, respectively. Disulfide bonded cysteines within the LE domains are depicted in ball-and-stick presentation
using different colors. Domain boundaries are indicated by dashed lines. P28 fits into a pocket shared by the LN and LE1 domain, and the N-terminal
residues are interacting with LE1. Disulfides and the free cysteine residue of the LN domain are indicated. (B) The electrostatic surface potential is
represented in the same orientation and on the same scale as in (A). Negative and positive potentials are shown in red and blue, respectively. Homology
based modeling was performed using Swiss-Model106 in manual alignment mode with the mouse b1 structure (pdb code 4aqs46) as a template.
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Figure 3. For figure lenged, see next page.
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apart from the C-terminus of the c chain is essential.55 This
residue is indeed highly conserved in the c1 and c2, but not c3
subunits. A lack of integrin a3β1 binding activity in the absence
of at least short β3 and c2 segments has been shown for a3 LG1-
LG3.54,56 The absence of such crucial parts of the β and c chains
could result in the open LG1-LG2 conformation (Fig. 3A and B)
and might not reflect the conformation of the native molecule.49
The LG3 and LG4 domains are connected by a flexible linker,
which was realized very early by the proteolytic susceptibility of
mouse laminin 111.45 Based on the C- and N-terminal residues,
which can be resolved in the mouse a5 LG1–3 (2wjs49) and a1
LG4–5 (2jd450) structures, respectively, for human a3 the termini
of the corresponding loop can be defined as N1310 and D1352
(Fig. 1B). Close to the middle, a3 LG is processed between Q1337
and D1338.17,57 This leaves a segment P1312PFLMLLKGSTR
attached to LG3 which, based on a recombinantly overexpressed
LG and synthetic peptide approach, was reported as crucial for
integrin a3β1 binding.58 C-terminally truncated peptides,
however, abolished this activity. The difference of this part in
mouse a3 (PPFLMLFKSPKG, Fig. 1B), however, would suggest
that this interaction is rather species specific.
Based on the structures of the mouse a1 and a2 LG4–5 pairs,
modeling predicts that human a3 C1354 within the loop region
forms a disulfide bond with C1617 in LG5 (Fig. 3C).
Corresponding cysteines within the loop and LG5 are found in
all laminin a chains down to Drosophila and C. elegans.
Interestingly, human a3 LG4 (C1443) and a1 LG3 contain
further cysteines in a similar position, which are not conserved in
mouse and rat. Within the model (Fig. 3C), the C1443 and C1587
SH groups point into the hydrophobic core of the β sandwich.
The crystal structures of mouse a5 LG1, LG2, and a1, a2
LG4, LG5 contain tightly bound calcium or magnesium ions
interacting with pairs of aspartate residues.20,49-51 Our human a3
LG models (Fig. 3) suggest that these cation binding sites are not
conserved. Although within LG1 and LG2 D827 and D1090,
respectively, are present, their partner residues are changed to
N910 and R1023. Within LG4 and LG5, the corresponding
residues are replaced by S1413/S1481 and K1584/S1654. This does
not exclude that a3 LG domains might contain other divalent
cation binding sites, but so far no conclusive experimental data
exist.
Due to their physiological relevance, many studies have been
performed to elucidate the interaction of laminins with
proteoglycans. As a model for the complex glycosaminoglycan
chains, most experiments are performed with heparin. We have
recently reported on the specific interaction of human a3 LG45
with syndecans and found that K1434, R1436 and K1438 are crucial
for syndecan-1 binding, whereas K1440 and K1442 show a
preference for syndecan-4 (see below).59 Using the modeled a3
LG4 domain and a truncated heparin-like structure (pdb code
1hpn),60 docking simulations predict that the carbohydrate chain
aligns to the concave surface of LG4 with the positively charged
residues filling the grooves formed by the repeating sulfates
(Fig. 3D and E).
Functions of LG45 in Precursor a3
A potential function for the tandem LG45 domains was initially
suspected based on the ability of laminin 332 to trigger distinct
cellular events depending on the level of processing of its a3
chain. A form of laminin 332 that lacked LG45 was found in
mature basement membranes, where it was shown to play an
important function in the nucleation and maintenance of
anchoring structures through a3β1 and a6β4 integrin interac-
tions.61-63 In contrast, laminin 332 with intact LG45 (a3200) was
found in migratory/remodelling situations such as epidermal
repair.64-66 Indeed, laminin 332 with an a3200 chain was found in
the ECM of keratinocytes migrating on collagen I or after
stimulation by TGF-β1.67,68 In vivo, epidermal injury activates the
transcription and deposition of laminin 332 into the provisional
matrix by the leading keratinocytes in the process of epidermal
outgrowth and migration at the wound edge.8,61,69 Noteworthy,
a3200 laminin 332 is found in this provisional matrix but is absent
from mature basement membranes.16,61,62 Recently, laminin 332
comprising an a3200 chain was proposed to be involved in the
invasion of squamous cell carcinomas in vivo.70 Polyclonal
antibodies targeting the LG45 domains induced squamous cell
carcinoma apoptosis in vivo and thus inhibited tumor
proliferation.70
Function in laminin 332/311 deposition into the ECM. A
function for LG45 in the deposition of laminin 332 in the ECM
has been first hypothesized by Carter and coworkers,16 who
Figure 3 (See previous page). Structural models of human laminin a3 LG domains. (A) The structure of LG1 to LG3 encompassing residues M771 to S1308
is shown as a cartoon as described for Figure 2 . All cysteine residues are depicted in space filling (CPK) style. The disulfide bridge between C941 and C971
(red dotted line) could not be correctly modeled as the template sequence has a shorter loop between the corresponding residues. All other cysteines
form disulfide bridges except for C840 in LG1 which side chain points into the inner space of the b-sandwich. (B) The electrostatic surface potential is
represented in the same orientation and on the same scale as in (A). Negative and positive potentials are shown in red and blue, respectively. (C) A
model of LG45 corresponding to residues C1354 to Q1713 is shown with all cysteines in CPK style. C1354 from the loop region connecting LG3 and LG4
forms an interdomain disulfide bond with C1617. C1443 in LG4 and C1587 in LG5 are pointed to the space between the b sheets of the sandwich structures
and are not surface accessible, whereas C1507-C1530 and C1682-C1710 form disulfide bonds. (D) A model of LG4 interacting with a heparin-like carbohydrate
chain consisting of four GlcNS(6S)-IdoA(2S) disaccharides (ball-and-stick representation with a surface envelope) is shown. The side chains of K1434, R1436,
and K1438, which were shown to be critically involved in syndecan-1 interaction are depicted in red, whereas those of K1440 and K1442 involved in
syndecan-4 interaction are shown in green.59 The ε-amino and guanidinium groups of the lysine and arginine residues, respectively, point to the sulfate
groups of the carbohydrate chains. (E) The surface view of the model shown in (D) indicates the tight packing of the heparin fragment into the groove
formed by the concave surface of the LG4 b-sandwich with positive surface potential spaced to fit the distance of sulfate groups. The template structures
used for modeling were mouse laminin a2 LG1-LG3 (pdb code: 2wjs)49 and mouse laminin a1 LG4-LG5 (2jd4, chain B).50 Docking of a heparin fragment
(1hpn)60 to LG4 was performed with PatchDock.107
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showed that exogenous human a3200 laminin 332, but not a3165
laminin 332, was trapped by cultured LAMA3 deficient mouse
keratinocytes and deposited within their ECM. Moreover, when
these keratinocytes were transfected with constructs encoding
either an LG45-uncleavable or a precleaved a3 chain, they
deposited a larger amount of the LG45-uncleavable laminin 332
into their ECM as compared with the LG45 pre-cleaved laminin
332 that was preferentially secreted into the culture medium. The
importance of LG45 in laminin 332 deposition was confirmed by
a study reporting that a mutant laminin 332 lacking the LG45
domain, stably expressed in laminin 332 null keratinocytes
derived from a patient with junctional epidermolysis bullosa (JEB)
with underlying LAMA3 gene mutations, was less retained in the
ECM but rather found in the culture medium as compared with
the WT.70 Co-expression of LG45 in these a3165 laminin
expressing keratinocytes enhanced laminin 332 deposition into
the ECM, reinforced keratinocyte adhesion to the ECM and
decreased migration. In these cells, LG45 co-localized with the a6
integrin subunit in stable adhesion contacts in a manner
comparable to the LG45 domain of WT laminin 332
keratinocytes.70
Another study, however, found no difference in laminin 332
deposited by keratinocytes expressing either LG45 uncleavable or
pre-cleaved laminin 332.19 Skin equivalents epithelialized with
keratinocytes expressing the a3165 laminin 332 displayed a
dermal-epidermal junction identical to that obtained with wild
type keratinocytes suggesting that a3165 laminin 332 was properly
deposited into the basement membrane or at least in an amount
sufficient to allow dermal-epidermal cohesion.19 Besides, skin
equivalents designed with keratinocytes expressing the LG45
uncleavable laminin 332 revealed absence of hemidesmosomes
accompanied by an appreciable thickening of the lamina lucida
likely secondary to the reduced cohesion of the tissue.19 These
experiments show that LG45 cleavage appears to be a prerequisite
for hemidesmosome formation in skin equivalent models.
These studies show that LG45 has the ability to integrate into
the keratinocyte ECM either on its own or when present in the
a3200 chain. It targets a6β4 integrin containing stable adhesion
contacts suggesting that it may play a role in a6β4 integrin
clustering in vitro. Although LG45 removal decreased laminin
332 deposition in the ECM, it did not fully prevent it, suggesting
that other mechanisms may contribute in controlling laminin 332
deposition.
Defective a3 and c2 processing was seen in cylindromatosis, a
rare genetic human disorder characterized by the occurrence of
multiple irregular benign epithelial tumors in the upper dermis.63
These nodules display a dramatically enlarged basement mem-
brane (up to 4.3 mm thickness) as well as ultrastructural
abnormalities as no clear lamina densa could be detected. The
different integrin receptors are found in improper ratios as β1
integrins are upregulated while a6β4 integrin expression and
hemidesmosome numbers are decreased.63 Despite a massive
accumulation of laminin 332 throughout the entire basal lamina,
a thin labeling of the LG45 domain detected at the interface
between cylindroma cells and the basal lamina suggests that the
LG45 processing may have been delayed. It is not clear whether
laminin 332 accumulation in the basement membrane is related
to this processing defect. Only one study reported a missense
mutation in the LAMA3 gene affecting LG4 in a patient with a
mild non-Herlitz JEB phenotype.71 This mutation resulting in
G1506E triggers an imperfect local protein folding that, without
impairing trimerization of the coiled coil, causes laminin 332
intracellular accumulation within the endoplasmic reticulum.
Only a small amount of the laminin 332 harboring the mutated
a3 chain is secreted and physiologically processed thus providing
partial adhesion functions and explaining the mild phenotype.
Therefore structural changes caused by mutations of this highly
conserved residue throughout laminin LG4 domains highlights
potential important functions of LG45 in laminin secretion.
When a laminin a3 cDNA was transfected into HT1080 cells,
the exogenous a3 chain was assembled with the endogenous
β3/c2 and β1/c1 to produce laminin 332 and laminin 311
heterotrimers.72 Out of the two laminin isoforms found in the
culture medium, laminin 311 was found primarily with a
precursor a3200 chain while the laminin 332 was found with an
a3165 chain.72 Sigle et al.16 showed that exogenous human a3200
laminin 311 was not trapped by cultured LAMA3 deficient mouse
keratinocytes nor deposited within their ECM like a3200 laminin
332 (see above). When these keratinocytes were transfected with
constructs encoding an LG45-uncleavable a3 chain, they
deposited large amount of LG45-uncleavable laminin 332 within
their ECM, and the LG45-uncleavable laminin 311 was found
exclusively in the culture medium.16 These results suggest that the
two laminin isoforms integrate within the basement membrane
through different mechanisms. That a3200 laminin 311 was not
deposited within the ECM first shows that LG45 could not fulfil
this event on its own. It also reinforces the hypothesis that a
protein domain present in laminin 332 but absent in laminin 311,
possibly in the c2 chain,73 may contribute to the laminin
deposition.
Since laminin 311 forms a complex with laminin 332 in vivo, it
is tempting to speculate that laminin 311 deposition within the
ECM might may depend on its covalent association with laminin
332. Most interestingly, co-polymers of perlecan with mature
laminin 311 were identified in ECM formed by alveolar epithelial
cells.74,75 Through nidogen linkage to the laminin 311 c1 chain,
perlecan was proposed to nucleate formation of laminin 311
fibrils.
Function in cell adhesion and migration. It has been proposed
that precursor laminin 332, together with integrin a3β1, plays a
central role in the polarization and migration of cells.12,66
Processing of the laminin 332 a chain was suggested to alter its
binding ability to various integrins by differential exposure of
binding sites/sequences to integrin receptors. Cell adhesion
studies have shown that immobilized purified a3200 laminin
332 promotes adhesion of keratinocytes, but to a lesser extent
than that obtained with mature laminin 332.76 Further analysis
revealed that the a3β1 integrin was the major receptor to interact
with a3200 laminin 332, while both a3β1 and a6β4 integrins
were involved in cell adhesion to a3165 laminin 332.76 These
findings correlate with previous results showing that cells plated
on an a3200 laminin 332 rich matrix failed to form a6β4
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integrin-dependent hemidesmosomes, whereas plasmin cleavage
of the LG45 domain inhibited migration and promoted
hemidesmosome formation.12 These data were corroborated by
studies showing that a3200 laminin 332 is a preferential ligand for
integrin a3β1 and/or a6β1, whereas processed a3 LG domains
are the preferred ligand for integrin a6β4.65 Besides, the analysis
of the binding capacity of soluble recombinant a3β1 integrin to a
mini-laminin 332 comprising the five LG domains has revealed
an increased affinity for integrin binding when LG45 was cleaved
off.56 Information gained from the structural model of the LG
predicts that LG1–3 have the shape of a cloverleaf from which
LG45 extends.7 The specific length of the LG3-LG4 linker results
in LG5 being closer to the LG1–3 cloverleaf than LG4 suggesting
that the integrin-binding domain may be differently exposed in
a3200 and a3165 laminin 332. Other studies have contradicted
this hypothesis as both a6β4 and a3β1 integrins were found to
interact with an LG45-uncleavable laminin 33216 and were
colocalized in precursor laminin 332 trails left behind migrating
cells.57 Moreover, a6β4 integrin containing stable anchoring
complexes77 were detected in cultured keratinocytes expressing
precursor- or LG45-uncleavable laminin 33216,19 in which LG45
and a6β4 integrins colocalized.70 Although the β4 integrin was
correctly expressed and localized at the apical side of the epidermal
basal layer, LG45-uncleavable laminin 332 expressing keratino-
cytes failed to form hemidesmosomes when seeded over a dermal
equivalent model.19
Other studies have reported that soluble LG45 may have a
function when released from laminin 332. Experiments have
shown that adding either recombinant a3LG45 or LG4 to the
culture medium could induce migration of keratinocytes in a
MMP-9-dependent manner.78 In similar experiments, LG4
induced activation of pro-migratory MMP-1.79 Moreover, Ras/
IkBa transformed keratinocytes that lacked the LG45 domain
showed a deficiency in MMP-9 and MMP-1 expression. This
deficiency was reversed by replacing LG45 through retroviral
transduction.70
Binding sites within a3 LG45. The mechanism underlying the
function of the LG45 domain in laminin 332 remains poorly
understood. Several heparin-binding sites have been identified in
the a3LG45 sequence (Table 1). Some of these conferred
heparin-dependent cell adhesion properties, which suggested that
this region in laminin 332 could interact with a heparan sulfate
proteoglycan receptor.29,59 An early report described the char-
acterization of a heparin-binding synthetic peptide corresponding
to residues K1398PRLQFSLDIQT derived from the murine a1
LG4 sequence.80 This peptide induces adhesion of the melanoma
cells B16F10 through an heparan sulfate proteoglycan type
receptor that remains to be identified. A peptidic screening of the
murine a3 LG45 domains allowed identification of three heparin
binding sites with cell adhesion properties.81 Peptidic screening of
the human sequence lead to the identification of a motif that
included residues N1412SFMALYLSKGR, which was shown to
induce syndecan-2 and -4 mediated cell adhesion, neurite
outgrowth and MMP-1 and -9 secretion.78,79,82,83 Further work
suggested that this motif also induced keratinocyte migration by
triggering syndecan-4 clustering and subsequent β1 integrin
activation.84 Later, three novel heparin-binding sites were
identified based on cross-linking the native protein to heparin
beads.85 Recently, through a site-directed mutagenesis approach to
alter the most critical basic residues in a recombinant LG45
protein, we identified a unique heparin-binding site surrounded
by a track of converging low affinity, positively charged
residues (Fig. 3D and E).49 We further showed that this
K1433KLRIKSKEK sequence region, which matches one of the
sites identified by Vives et al.85 harbours distinctive syndecan-1
and -4 interaction sites (Table 1). Besides, our group has reported
that syndecan-1 is the cellular receptor involved in cell adhesion to
the a3 LG45 domain57,86 and this interaction may participate in
keratinocyte migration by supporting the formation of actin-based
cellular protrusions (Fig. 4A and B).76,87 The development of
these membrane protrusions remarkably requires dephosphoryla-
tion of tyrosine residues in the cytoplasmic tail of syndecan-1, a
condition essential for syntenin-1 recruitment.87,88 In the
epidermis, syndecan-1 is located in the pericellular region of
keratinocytes and displays a modest expression in the basal cell
layer, which becomes increasingly intense in the suprabasal layers.
Remarkably, syndecan-1 is strongly induced in wound edge
keratinocytes during wound healing.89-91 This elevated expression
Table 1. Heparin binding sites identified within human and mouse LG45 domains
Laminin a3 LG45 heparin binding sites Method used for identification Binding partner References
Human
N1412SFMALYLSKGR Peptide Syndecan-2
Syndecan-4
82
L1428GTDGKKLRIKSKEKCNDG LG45/heparin cross-link Heparin 85
K1433KLRIK Directed mutagenesis Syndecan-1 59
R1436IKSKEK Directed mutagenesis Syndecan-4 59
L1488GSPPSGKPKSL LG45/heparin cross-link Heparin 85
V1610TPKQSLCD LG45/heparin cross-link Heparin 85
Mouse
K1336ARSFNVNQLLQD Peptide Unknown receptor 81
D1398PRLQFSLDIQT Peptide Unknown receptor 81
D1629GQWHSVTVSIK Peptide Unknown receptor 81
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in keratinocytes appears to be specific to syndecan-1 as no changes
have been detected for other syndecans.92 Moreover, syndecan-1
deficient mice display a defect in keratinocyte proliferation and
migration during wound healing.93 In light of these data,
syndecan family members stimulate interest as potential laminin
332 co-receptors. Recent data has provided evidence that when
human squamous carcinoma A431 cells are plated on laminin
332, syndecan-1 forms a complex with the a6β4 integrin. This
triggers Fyn-mediated phosphorylation of the β4 integrin
cytoplasmic tail activating PI3K- and Akt-mediated signaling,
protecting the cells against apoptosis.94 This is of particular
interest as LG45 in a3200 laminin 332 was proposed as an
essential PI3K pathway activation promoter.70
Functions of Precursor c2 N-Terminal Domain
It has been shown that in human skin basement membrane, the
N-terminal domain of the c2 chain is absent suggesting that the
c2 processing could have an important physiological role.11,63 In
contrast to these findings, antibodies specific for the released L4
domain were shown to label the basal epidermal cells in mouse
skin.24 A positive signal was also found in the basement
membranes of early stages of skin development suggesting that
the precursor c2 chain or its released N-terminal domain
expression might persist in vivo.24 The analysis of mTLD/BMP-
1 deficient mice revealed that although defaults in skin cohesion
were not clinically apparent, ultrastructural examination of the
basement membrane showed places where anchoring structures
were disconnected at the level of the lamina densa with presence
of rudimentary hemidesmosomes.15,25 A strong expression of the
precursor c2 chain suggested that c2 chain maturation takes part
in the basement membrane cohesion and stability. Besides,
defective c2 processing was found in the rare inherited
cylindromatosis disease (see above), in which abnormal basement
membranes and excessive ectopic expression of collagen VII were
found.63,96 The defective processing of the c2 chain may have
resulted in a deficient interaction with its basement membrane
partners collagen VII causing defaults in anchoring fibrils
linkage.32,95
Numerous studies conducted with normal breast epithelial and
carcinoma cells have shown that cell migration-inducing functions
of the c2 chain rely on its proteolysis.35 Recently, it has been
reported that a syndecan-1 interaction with the N-terminal
domain in precursor c2 could negatively regulate β4 integrin
phosphorylation leading to enhanced carcinoma cell adhesion and
decreased motility97 reinforcing the idea that the precursor c2
chain does not support cell migration. In contrast, other reports
have suggested that precursor c2 may play a role in keratinocyte
migration during the wound healing process. An interaction of its
N-terminal portion with a2β1 integrin was shown to occur
during TGF-β1 induced keratinocyte migration in vitro and was
proposed to take place at the wound margin of the skin healing
process in vivo.68 Keratinocytes at the edge of wounds made in
early passage cultures shown to co-express the laminin 332 c2
chain and the cell cycle inhibitor p16INK4a, displayed increased
directional motility.98 Additional studies revealed that this
keratinocyte hypermotility/growth arrest response relied on both
the precursor state of the laminin 332 c2 chain and the
participation of a serum co-factor through a TGFβ receptor I
dependent mechanism.99 This apparent contradiction in experi-
mental findings is likely due to tissue specific differences. A study
indicated that the L4 module mediates the integration of laminin
332 into the extracellular matrix through intermolecular
interactions.73
The question arises whether the heparin-binding domains
located within the a3 LG45 domains and the N-terminal
portion of the c2 chain are involved in laminin 332 deposition.
Heparin was shown to inhibit laminin 332 deposition within the
ECM suggesting that a heparan sulfate proteoglycan might be
involved in binding to both precursor a3 and c2.13 Null
mutation in syndecan-1100 and -4101 has not reported defects in
laminin deposition, which suggests that any of these two
receptors is solely responsible for this mechanism. Generation of
double syndecan-1 and -4 knockout mice would reveal whether
both these receptors are implicated. Future studies should
examine whether a heparan sulfate proteoglycan cell surface
receptor or a basement membrane components are is implicated
in precursor laminin 332 deposition. Interestingly, a recent study
has reported that the perlecan colocalizes with laminin 332 at the
wound margin of healing full thickness wounds generated in
mice suggesting proximity of these two components during
basement membrane remodelling.102 However, as perlecan was
shown not to be essential for matrix assembly in perlecan-null
mouse embryos,103 its presence in the ECM might not be an
absolute requirement for laminin 332 deposition. Considering
the important function of laminin 332 in skin homeostasis,
several extracellular ligands might be involved in its deposition in
the basement membrane.
Figure 4. Syndecan-1 mediated cell adhesion to laminin 332 LG45
domain. (A) Fibrosarcoma HT1080 cells were plated on surfaces coated
with purified LG45 domain for 1 h, fixed and stained with phalloidin-
FITC. The analysis of the actin staining revealed an organization of the
cytoskeleton in radial arrays of microspikes, protrusive adhesion
structures known to be involved in transient cell-substratum interactions.
(B) Confocal image of HT1080 cells expressing GFP-syndecan-1 plated on
the LG45 domain. The phase contrast image shows the typical induced
cell shape characterized by the formation of spike-like actin-based
protrusive structures. The receptor syndecan-1 (green) promotes cell
adhesion to the laminin fragment and aligns along the actin filaments,
which are organized into parallel bundles. Bars, 10 mm.
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Conclusions
Comprehension of the physiological significance of laminin 332
maturation events remains an open issue. Numerous studies have
focused on the LG45 and c2 N-terminal domains suggesting their
involvement in diverse important functions such as laminin
secretion, deposition and/or retention within the ECM; others
have suggested a participation in epithelial cell adhesion and
migration processes. However, their exact function remains
unknown. While in vitro data sometimes disagree due to the
cellular system’s diversity, in vivo models firmly demonstrate that
defects in laminin 332 maturation impede correct basement
assembly as well as hemidesmosome formation. Molecular
interaction abnormalities occur at the level of cellular receptors
and basement membrane components causing both functional
and organisational anomalies. Molecular characterization and
structural definition of laminin domains open interesting and
every so often unexpected questions. From its identification in the
1990s9,26,104,105 to nowadays, laminin 332 has stimulated
incessantly increasing interest in the scientific community due
to its multifunctional properties and its involvement in human
physiological processes and pathologies.
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